Antibodies News and Research

RSS

Abselion introduces Protein G Total Antibody Quantification Kit

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced the launch of its Protein G Total Antibody Quantification Kit.

From Abselion 22 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

New NIH grant supports development of experimental pediatric HIV vaccine

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine.

18 Sep 2025

Tracking antibodies reveals four distinct COVID-19 vaccine responses

Two healthcare workers get COVID-19 vaccinations on the same day. Both show strong antibody responses initially, but six months later one stays healthy while the other contracts the virus. A new study published in Science Translational Medicine could help explain this difference.

18 Sep 2025

New molecule offers a more targeted and potent immunotherapy

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel, Switzerland, have demonstrated that this fusion protein can both block the "do not attack" signal used by cancer cells and selectively activate tumor-fighting immune cells. This dual action could pave the way for more effective cancer therapies with fewer side effects.

18 Sep 2025

Holder vs Retort: How milk pasteurization shapes preterm infants’ gut health

Researchers at Vanderbilt University Medical Center found that pasteurization methods shape the gut microbiomes of preterm infants fed donor human milk. Holder pasteurization preserved microbial diversity and beneficial taxa better than Retort, producing microbiomes more similar to those from mothers’ own milk.

17 Sep 2025

Florida chickens help scientists forecast West Nile virus outbreaks

A new study has significant bearing on the hackneyed joke about chickens and their numerous reasons for crossing roads.

17 Sep 2025

Lymphatic vessels found to undergo dramatic changes during kidney transplant rejection

Scientists have uncovered how lymphatic vessels – the kidney's 'plumbing system' – undergo dramatic changes during chronic transplant rejection, becoming structurally disorganised and spreading to unusual parts of the kidney.

16 Sep 2025

Triple negative breast cancer exploits lymph node niches to block immune defense

In almost all solid tumors - i.e. cancers with a solid tissue structure - the detection of tumor cells in the lymph nodes is considered a decisive marker for the progression of the disease.

16 Sep 2025

SwRI and UT San Antonio advance biosensor coating to streamline production of immunotherapies

Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UT San Antonio) are advancing a smart biosensor coating to streamline the production of immunotherapies for cancer treatments.

15 Sep 2025

Beckman Coulter Life Sciences launches industry-first infrared dye antibody conjugates to expand human phenotyping experiments

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody conjugates.

From Beckman Coulter Life Sciences - Flow Cytometry 15 Sep 2025

Early B cell response prevents Oropouche virus from reaching the brain

Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.

14 Sep 2025

UCLA team develops engineered antibodies to fight cytomegalovirus infection

A UCLA research team has found a new way to prompt the immune system to kill cells infected with cytomegalovirus (CMV), a life-threatening infection that is particularly deadly in immunocompromised people.

13 Sep 2025

Waning Japanese encephalitis immunity linked to more severe dengue illness

Scientists from Duke-NUS Medical School, in collaboration with researchers in Nepal, have found that waning immunity to Japanese encephalitis virus (JEV) may increase the risk of more severe dengue disease in humans.

13 Sep 2025

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors.

From Sino Biological Inc. 13 Sep 2025

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

From BioDlink 12 Sep 2025

Breakthrough findings point to future treatments for juvenile dermatomyositis

Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH).

11 Sep 2025

Weill Cornell Medicine receives $3.4 million NIH grant to study type 1 diabetes development

Weill Cornell Medicine has received a four-year, $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, for a study of the details and dynamics of the autoimmune process that causes type 1 diabetes.

11 Sep 2025

Antibody cocktail could change the way the world fights influenza

An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one of the deadliest infectious diseases.

11 Sep 2025

Novel method accurately identifies therapeutic antibodies to treat infectious diseases

Scientists at Scripps Research have developed a novel method that uses artificial intelligence (AI) and advanced imaging techniques to more accurately and efficiently identify therapeutic antibodies to treat infectious diseases.

10 Sep 2025

Antibodies News and Research

Abselion introduces Protein G Total Antibody Quantification Kit

New findings support low-dose ATG to delay progression of type 1 diabetes

New NIH grant supports development of experimental pediatric HIV vaccine

Tracking antibodies reveals four distinct COVID-19 vaccine responses

New molecule offers a more targeted and potent immunotherapy

Holder vs Retort: How milk pasteurization shapes preterm infants’ gut health

Florida chickens help scientists forecast West Nile virus outbreaks

Lymphatic vessels found to undergo dramatic changes during kidney transplant rejection

Triple negative breast cancer exploits lymph node niches to block immune defense

SwRI and UT San Antonio advance biosensor coating to streamline production of immunotherapies

Beckman Coulter Life Sciences launches industry-first infrared dye antibody conjugates to expand human phenotyping experiments

Early B cell response prevents Oropouche virus from reaching the brain

UCLA team develops engineered antibodies to fight cytomegalovirus infection

Waning Japanese encephalitis immunity linked to more severe dengue illness

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

Breakthrough findings point to future treatments for juvenile dermatomyositis

Weill Cornell Medicine receives $3.4 million NIH grant to study type 1 diabetes development

Antibody cocktail could change the way the world fights influenza

Novel method accurately identifies therapeutic antibodies to treat infectious diseases

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo